Kenalog-40 Injection, Suspension
Product Images NDC 76420-085

2 FDA label images from Asclemed Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Kenalog-40 (NDC 76420-085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Triamcinolone Acetonide Chemical Structure (Kenalog Struct)

Image Triamcinolone Acetonide Chemical Structure (Kenalog Struct)
Chemical structure of triamcinolone acetonide, the active ingredient in KENALOG-40 injection suspension. The structure shows multiple fused rings with hydroxyl, carbonyl, fluorine, and acetonide functional groups.*
FDA Label Image

Label (Kenalog40 1ml Label)

Label (Kenalog40 1ml Label)
The label for Kenalog-40 (40 mg/mL) injection suspension, a human prescription drug with NDC 76420-085-01. The label shows it is relabeled by Enovachem Pharmaceuticals and distributed by Bristol Meyer Squibb Company. It includes product identifiers such as QR code, barcodes, drug status as prescription only, and storage instructions. The suspension is white in color with a quantity of 1 indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.